Back
  1. Home
  2. Profile of Akos Gulyban (ULiège)
Profil

Gulyban Akos

See author's contact details
Main Referenced Co-authors
Coucke, Philippe  (16)
Poortmans, P. (9)
Lakosi, Ferenc (7)
Weber, D. C. (7)
Collette, L. (6)
Main Referenced Keywords
Humans (15); Radiotherapy (9); Quality assurance (8); Radiotherapy Dosage (8); Quality Assurance, Health Care (6);
Main Referenced Unit & Research Centers
Montefiore Institute - Montefiore Institute of Electrical Engineering and Computer Science - ULiège [BE] (1)
Main Referenced Disciplines
Radiology, nuclear medicine & imaging (31)
Oncology (15)
Computer science (2)
Electrical & electronics engineering (1)
Human health sciences: Multidisciplinary, general & others (1)

Publications (total 47)

The most downloaded
2242 downloads
Harkati, R., Bare, M., GULYBAN, A., Dechambre, D., Berkovic, P., & Coucke, P. (2017). Hemangiomes vertebraux multiples traites simultanement en condition stereotaxique avec la technologie CyberKnife(R). Revue Médicale de Liège, 72 (7-8), 349-353. https://hdl.handle.net/2268/234261

The most cited

109 citations (Scopus®)

Matzinger, O., Gerber, E., Bernstein, Z., Maingon, P., Haustermans, K., Bosset, J. F., GULYBAN, A., Poortmans, P., Collette, L., & Kuten, A. (2009). EORTC-ROG expert opinion: Radiotherapy volume and treatment guidelines for neoadjuvant radiation of adenocarcinomas of the gastroesophageal junction and the stomach. Radiotherapy and Oncology, 92 (2), 164-175. doi:10.1016/j.radonc.2009.03.018 https://hdl.handle.net/2268/150877

Berkovic, P., GULYBAN, A., Defraene, G., Swenen, L., Dechambre, D., NGUYEN, P. V., Jansen, N., MIEVIS, C., LOVINFOSSE, P., Janvary, L., Lambrecht, M., & De Meerleer, G. (2020). Stereotactic robotic body radiotherapy for patients with oligorecurrent pulmonary metastases. BMC Cancer, 20 (1), 402. doi:10.1186/s12885-020-06906-1
Peer Reviewed verified by ORBi

Kahan, Z., Rarosi, F., Gaal, S., Cserhati, A., Boda, K., Darazs, B., Koszo, R., Lakosi, F., GULYBAN, A., COUCKE, P., & Varga, Z. (2018). A simple clinical method for predicting the benefit of prone vs. supine positioning in reducing heart exposure during left breast radiotherapy. Radiotherapy and Oncology. doi:10.1016/j.radonc.2017.12.021
Peer Reviewed verified by ORBi

Berkovic, P., GULYBAN, A., Nguyen, P. V., DECHAMBRE, D., Martinive, P., JANSEN, N., Lakosi, F., Janvary, L., & Coucke, P. (20 March 2017). Stereotactic Robotic Body Radiotherapy for Patients With Unresectable Hepatic Oligorecurrence. Clinical Colorectal Cancer, 16 (4), 349-357.e1. doi:10.1016/j.clcc.2017.03.006
Peer Reviewed verified by ORBi

Paelinck, L., GULYBAN, A., Lakosi, F., Vercauteren, T., De Gersem, W., Speleers, B., Monten, C., Mulliez, T., Berkovic, P., van Greveling, A., Decoster, F., Coucke, P., De Neve, W., & Veldeman, L. (2017). Does an integrated boost increase acute toxicity in prone hypofractionated breast irradiation? A randomized controlled trial. Radiotherapy and Oncology, 122 (1), 30-36. doi:10.1016/j.radonc.2016.12.023
Peer Reviewed verified by ORBi

Harkati, R., Bare, M., GULYBAN, A., Dechambre, D., Berkovic, P., & Coucke, P. (2017). Hemangiomes vertebraux multiples traites simultanement en condition stereotaxique avec la technologie CyberKnife(R). Revue Médicale de Liège, 72 (7-8), 349-353.
Peer reviewed

Vandaele, R., LALLEMAND, F., MARTINIVE, P., GULYBAN, A., JODOGNE, S., COUCKE, P., Geurts, P., & Marée, R. (2017). Automated multimodal volume registration based on supervised 3D anatomical landmark detection. In SCITEPRESS Digital Library.
Peer reviewed

Janvary, Z. L., JANSEN, N., BAART, V., DEVILLERS, M., DECHAMBRE, D., LENAERTS, E., SEIDEL, L., BARTHELEMY, N., BERKOVIC, P., GULYBAN, A., lakosi, F., zsolt, H., & COUCKE, P. (2017). Clinical outcomes of 130 patients with primary and secondary lung tumors treated with Cyberknife robotic stereotactic body radiotherapy. Radiology and Oncology, 51 (2), 178-186. doi:10.1515/raon-2017-0015
Peer Reviewed verified by ORBi

Lakosi, F., GULYBAN, A., BEN MUSTAPHA, S., NGUYEN, V. P., CUCCHIARO, S., SEIDEL, L., JANVARY, L., NICOLAS, S., VAVASSIS, P., & COUCKE, P. (July 2016). The Influence of Treatment Position (Prone vs. Supine) on Clip Displacement, Seroma, Tumor Bed and Partial Breast Target Volumes: Comparative Study. Pathology Oncology Research, 22 (3), 493-500. doi:10.1007/s12253-015-0028-3
Peer Reviewed verified by ORBi

Lakosi, F., GULYBAN, A., BEN MUSTAPHA, S., NGUYEN, V. P., BERKOVIC, P., NOEL, M., GOURMET, N., & COUCKE, P. (15 May 2016). Feasibility evaluation of prone breast irradiation with the Sagittilt© system including residual-intrafractional error assessment. Cancer Radiotherapie, 3429. doi:10.1016/j.canrad.2016.05.014
Peer Reviewed verified by ORBi

Vandaele, R., Marée, R., COUCKE, P., GULYBAN, A., LALLEMAND, F., Geurts, P., JODOGNE, S., & MARTINIVE, P. (April 2015). Automated Landmark Detection For Rigid Registration Between The Simulation-CT and the Treatment CBCT [Poster presentation]. 3rd ESTRO FORUM, Barcelone, Spain.

Lakosi, F., GULYBAN, A., Janvary, L., Simoni, S. B.-M., Jansen, N., SEIDEL, L., Kovacs, A., Vavassis, P., & Coucke, P. (2015). Respiratory Motion, Anterior Heart Displacement and Heart Dosimetry: Comparison Between Prone (Pr) and Supine (Su) Whole Breast Irradiation. Pathology Oncology Research. doi:10.1007/s12253-015-9932-9
Peer Reviewed verified by ORBi

GULYBAN, A., Mackenzie, M., Mathot, M., Barthelemy, N., & Lakosi, F. (2015). Palliative Radiotherapy Delivery Technologies. In A. Fairchild (Ed.), Palliative Radiation Therapy: Utilization of Advanced Technologies. Nova.
Peer reviewed

LAKOSI, F., DE CUYPERE, M., NGUYEN, V. P., JANSEN, N., WARLIMONT, B., GULYBAN, A., GENNIGENS, C., SEIDEL, L., DELBECQUE, K., COUCKE, P., HERMESSE, J., & KRIDELKA, F. (2015). Clinical efficacy and toxicity of radio-chemotherapy and magnetic resonance imaging-guided brachytherapy for locally advanced cervical cancer patients : a mono-institutional experience. Acta Oncologica, 54 (9), 1558-1566. doi:10.3109/0284186X.2015.1062542
Peer Reviewed verified by ORBi

Devillers, M., Lakosi, F., Janvary, L., Ben Mustapha, S., Lenaerts, E., Coucke, P., & GULYBAN, A. (2014). Streamlined clinical CBCT protocols: Reduced dose and variation and maintained image quality. Radiotherapy and Oncology, ESTRO 33, 1738.
Peer Reviewed verified by ORBi

Cucchiaro, S., Dechambre, D., Ernst, C., Martin, N., Sequenzia, F., Ben Mustapha, S., Lakosi, F., Coucke, P., & GULYBAN, A. (2014). Clinical introduction of an all-in class solution for prone breast hypofractionated SIB with multibeam IMRT. Radiotherapy and Oncology, ESTRO 33, 0090.
Peer Reviewed verified by ORBi

Lakosi, F., Ben Mustapha, S., GULYBAN, A., Cucchiaro, S., Ernst, C., Martin, N., Sequenzia, F., & Coucke, P. (2014). Hypofractionated whole prone breast RT using Sagittilt system: patient comfort, setup accuracy and acute toxicity. Radiotherapy and Oncology, ESTRO 33, 1204.
Peer Reviewed verified by ORBi

Fairchild, A., Langendijk, J. A., Nuyts, S., Scrase, C., Tomsej, M., Schuring, D., GULYBAN, A., Ghosh, S., Weber, D. C., & Budach, W. (2014). Quality assurance for the EORTC 22071¿26071 study: dummy run prospective analysis. Radiation Oncology, 9 (1), 248. doi:10.1186/s13014-014-0248-9
Peer Reviewed verified by ORBi

GULYBAN, A., Cucchiaro, C., Mathot, M., Ernst, C., Martin, N., Sequenzia, F., Ben Mustapha, S., Coucke, P., & Lakosi, F. (2014). Combined FiF+ Tangent-to-tangents VMAT breast SIB technique: Clinical introduction of an optimal class solution. Radiotherapy and Oncology, ESTRO 33, 0142.
Peer Reviewed verified by ORBi

Ben Mustapha, S., Dechambre, D., Mievis, C., Coucke, P., Cucchiaro, C., GULYBAN, A., & Lakosi, F. (2014). Patterns of difficult cases for breast irradiation: where multi-beam IMRT and SIB should be the primary choice. Radiotherapy and Oncology, ESTRO 33, 1197.
Peer Reviewed verified by ORBi

Fenton, P. A., Hurkmans, C., GULYBAN, A., van der Leer, J., Matzinger, O., Poortmans, P., Collette, L., & Bolla, M. (2013). Quality assurance of the EORTC 22043-30041 trial in post-operative radiotherapy in prostate cancer: Results of the Dummy Run procedure. Radiotherapy and Oncology. doi:10.1016/j.radonc.2013.04.020
Peer Reviewed verified by ORBi

Fairchild, A., Aird, E., Fenton, P. A., Gregoire, V., GULYBAN, A., Lacombe, D., Matzinger, O., Poortmans, P., Ruyskart, P., Weber, D. C., & Hurkmans, C. W. (2012). EORTC Radiation Oncology Group quality assurance platform: Establishment of a digital central review facility. Radiotherapy and Oncology, 103 (3), 279-286. doi:10.1016/j.radonc.2012.04.015
Peer Reviewed verified by ORBi

Fairchild, A., Collette, L., Hurkmans, C. W., Baumert, B., Weber, D., GULYBAN, A., & Poortmans, P. (2012). 139 DOES QUALITY OF RADIOTHERAPY PREDICT OUTCOMES OF MULTICENTRE CLINICAL TRIALS? THE EORTC RADIATION ONCOLOGY GROUP EXPERIENCE. Radiotherapy and Oncology, 102, 62-S63. doi:10.1016/S0167-8140(12)70111-1
Peer Reviewed verified by ORBi

Fairchild, A., Weber, D. C., Bar-Deroma, R., GULYBAN, A., Fenton, P. A., Stupp, R., & Baumert, B. G. (2012). Quality assurance in the EORTC 22033-26033/CE5 phase III randomized trial for low grade glioma: The digital individual case review. Radiotherapy and Oncology, 103 (3), 287-292. doi:10.1016/j.radonc.2012.04.002
Peer Reviewed verified by ORBi

Nalbantov, G., De Ruysscher, D., Vandecasteele, K., GULYBAN, A., De Neve, W., Dekker, A., Hanbeukers, B., Oberije, C., & Lambin, P. (2012). OC-0501 IRRADIATION OF THE LEFT VENTRICLE OF THE HEART IS CORRELATED WITH POST-TREATMENT DYSPNEA IN NSCLC PATIENTS. Radiotherapy and Oncology, 103, 201-S202. doi:10.1016/S0167-8140(12)70840-X
Peer Reviewed verified by ORBi

Fairchild, A., Collette, L., Hurkmans, C. W., Baumert, B., Weber, D. C., GULYBAN, A., & Poortmans, P. (2012). Do results of the EORTC dummy run predict quality of radiotherapy delivered within multicentre clinical trials? European Journal of Cancer, 48 (17), 3232-3239. doi:10.1016/j.ejca.2012.06.002
Peer Reviewed verified by ORBi

GULYBAN, A., Oltenau, A. M. L., Vercauteren, T., Speleers, B., De Gersem, W., Van Geel, N., Paelinck, L., Van Eijkeren, M., De Wagter, C., & De Neve, W. (2012). EP-1420 ADAPTIVE CLINICAL COMMISSIONING OF MONACO VMAT: MAXIMIZING EFFICACY WITHOUT SACRIFICING SAFETY. Radiotherapy and Oncology, 103, 541. doi:10.1016/S0167-8140(12)71753-X
Peer Reviewed verified by ORBi

Sebestyen, Z., Kovacs, P., GULYBAN, A., Farkas, R., Bellyei, S., Liposits, G., Szigeti, A., Esik, O., Derczy, K., & Mangel, L. (2011). Conkiss: conformal kidneys sparing 3D noncoplanar radiotherapy treatment for pancreatic cancer as an alternative to IMRT. Medical Dosimetry, 36 (1), 35-40. doi:10.1016/j.meddos.2009.11.001
Peer Reviewed verified by ORBi

GULYBAN, A., Fenton, P. A., Fairchild, A., Aird, E., Grégoire, V., Lacombe, D., Matzinger, O., Poortmans, P., Baumert, B. G., Pascal, R., Weber, D. C., & Hurkmans, C. W. (2011). 182 oral EORTC RADIOTHERAPY QUALITY ASSURANCE PLATFORM: ESTABLISHMENT OF AN INTEGRATED CENTRAL REVIEW FACILITY. Radiotherapy and Oncology, 99, 71-S72. doi:10.1016/S0167-8140(11)70304-8
Peer Reviewed verified by ORBi

Sebestyén, Z., Kovács, P., GULYBAN, A., Farkas, R., Bellyei, S., Szigeti, A., Gallainé, D. F., & Mangel, L. (2011). Modern három dimenziós konformális craniospinalis besugárzási technika. Magyar Onkologia, 55 (3), 187-192.
Peer Reviewed verified by ORBi

Kovács, P., Sebestyén, Z., Farkas, R., Bellyei, S., Szigeti, A., GULYBAN, A., Horváth, Z., Dóczi, T., & Mangel, L. (2011). Konformális sztereotaxiás együléses sugársebészeti kezelés: tervértékelési módszerek és eredmények. Magyar Onkologia, 55 (2), 85-90.
Peer Reviewed verified by ORBi

Weber, D. C., Poortmans, P. M. P., Hurkmans, C. W., Aird, E., GULYBAN, A., & Fairchild, A. (2011). Quality assurance for prospective EORTC radiation oncology trials: The challenges of advanced technology in a multicenter international setting. Radiotherapy and Oncology, 100 (1), 150-156. doi:10.1016/j.radonc.2011.05.073
Peer Reviewed verified by ORBi

Duchateau, M., Verellen, D., Depuydt, T., Tournel, K., Reynders, T., Gevaert, T., Leysen, K., GULYBAN, A., Poels, K., & de Ridder, M. (2011). 69 speaker 3D DOSIMETRY SYSTEMS-GELS, EPIDS AND OTHERS. Radiotherapy and Oncology, 99, 27. doi:10.1016/S0167-8140(11)70192-X
Peer Reviewed verified by ORBi

Fairchild, A., GULYBAN, A., Denis, J. M., Vynckier, S., Hernandez, N., Molineu, A., Followill, D., Fenton, P. A., Weber, D. C., Hurkmans, C. W., & Grégoire, V. (2011). 392 poster INTERNATIONAL IMRT CREDENTIALING BY PHYSICAL PHANTOM IRRADIATION: THE EORTC ROG EXPERIENCE. Radiotherapy and Oncology, 99, 155. doi:10.1016/S0167-8140(11)70514-X
Peer Reviewed verified by ORBi

Matzinger, O., Heimsoth, I., Poortmans, P., Collette, L., Struikmans, H., Bogaert, W. V. D., Fourquet, A., Bartelink, H., Ataman, F., GULYBAN, A., Pierart, M., & Tienhoven, G. V. (2010). Toxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage i to III breast cancer (EORTC trial 22922/10925). Acta Oncologica, 49 (1), 24-34. doi:10.3109/02841860903352959
Peer Reviewed verified by ORBi

Musat, E., Roelofs, E., Bar-Deroma, R., Fenton, P., GULYBAN, A., Collette, L., Stupp, R., Weber, D. C., Davis, J. B., Aird, E., & Baumert, B. G. (2010). Dummy run and conformity indices in the ongoing EORTC low-grade glioma trial 22033-26033: First evaluation of quality of radiotherapy planning. Radiotherapy and Oncology, 95 (2), 218-224. doi:10.1016/j.radonc.2010.03.005
Peer Reviewed verified by ORBi

Matzinger, O., Gerber, E., Bernstein, Z., Maingon, P., Haustermans, K., Bosset, J. F., GULYBAN, A., Poortmans, P., Collette, L., & Kuten, A. (2009). EORTC-ROG expert opinion: Radiotherapy volume and treatment guidelines for neoadjuvant radiation of adenocarcinomas of the gastroesophageal junction and the stomach. Radiotherapy and Oncology, 92 (2), 164-175. doi:10.1016/j.radonc.2009.03.018
Peer Reviewed verified by ORBi

Matzinger, O., Poortmans, P., Giraud, J.-Y., Maingon, P., Budiharto, T., van den Bergh, A. C. M., Davis, J. B., Musat, E., Ataman, F., Huyskens, D. P., GULYBAN, A., & Bolla, M. (2009). Quality assurance in the 22991 EORTC ROG trial in localized prostate cancer: Dummy run and individual case review. Radiotherapy and Oncology, 90 (3), 285-290. doi:10.1016/j.radonc.2008.10.022
Peer Reviewed verified by ORBi

Matzinger, O., Duclos, F., Bergh, A. V. D., Carrie, C., Villà, S., Kitsios, P., Poortmans, P., Sundar, S., van der Steen-Banasik, E. M., GULYBAN, A., Collette, L., & Bolla, M. (2009). Acute toxicity of curative radiotherapy for intermediate- and high-risk localised prostate cancer in the EORTC trial 22991. European Journal of Cancer, 45 (16), 2825-2834. doi:10.1016/j.ejca.2009.07.009
Peer Reviewed verified by ORBi

GULYBAN, A., Hortobágyi, E., Sebestyén, Z., Kovács, P., Liposits, G., Farkas, R., Hideghéty, K., Mangel, L., & Ésik, O. (2008). Improving patient positioning accuracy for breast cancer radiation therapy by using the infra red based ExacTrac system. Nowotwory, 58 (5), 435-437.
Peer Reviewed verified by ORBi

GULYBAN, A., Kovács, P., Sebestyén, Z., Farkas, R., Csere, T., Karácsonyi, G., Dérczy, K., Hideghéty, K., & Ésik, O. (2008). Multisegmented tangential breast fields: A rational way to treat breast cancer. Strahlentherapie und Onkologie, 184 (5), 262-269. doi:10.1007/s00066-008-1770-1
Peer Reviewed verified by ORBi

GULYBAN, A., Kovacs, P., Farkas, R., Sebestyen, Z., Derczy, K., Hideghety, K., & Esik, O. (2007). Multisegmented radiation therapy as an alternative to 3D conformal radiation therapy, with special reference to breast cancer tangential fields. Nowotwory, 57 (3), 291-293.
Peer Reviewed verified by ORBi

GULYBAN, A., Kovács, P., Bellyei, S., Farkas, R., Strassz, A., Foldvari, D., Derczy, K., Sebestyén, Z., Hideghéty, K., & Esik, O. (2006). Multisegmented tangential breast fields: an effective step towards IMRT without a significantly higher secondary cancer risk. Radiotherapy and Oncology, 81 (suppl 1), 172.
Peer Reviewed verified by ORBi

Al-Farhat, Y., Kovács, P., GULYBAN, A., Farkas, R., Liposits, G., Boronkai, A., Kelemen, D., & Ésik, O. (2006). Radiochemothreapy for stage III pancreatic cancer. Radiotherapy and Oncology, 81 (suppl1), 303.
Peer Reviewed verified by ORBi

Hideghéty, K., Kahan, Z., Thurzo, L., GULYBAN, A., Farkas, R., Bellyei, S., Esik, O., Mitine, C., & Slosarek, K. (2006). Interim Report on clinical testing of a comprehensive solution for patient positioning and immobilization for high tech RT. Radiotherapy and Oncology, 81 (supplement 1), 434.
Peer Reviewed verified by ORBi

Farkas, R., Al-Farhat, Y., GULYBAN, A., Kovács, P., Bellyei, S., Csere, T., Stefanits, K., Derczy, K., Horvath, O. P., Illenyi, L., Sule, N., Szilagyi, K., Bogner, B., & Esik, O. (2006). Neoadjuvant Radiochemotherapy of Locally/Regionally Advanced Rectal Cancer is a standard treatment option. Radiotherapy and Oncology, 81 (suppl1), 237.
Peer Reviewed verified by ORBi

Nemeskéri, C., Póti, Z., Mayer, A., Trón, L., GULYBAN, A., Sáfrány, G., & Ésik, O. (2006). Induced acute erythema and late pigmentation may not be correlated: In regards to Perera et al. (Int J Radiat Oncol Biol Phys 2005;62:1283-1290) [letter to the editor]. International Journal of Radiation, Oncology, Biology, Physics, 65 (1), 309-310. doi:10.1016/j.ijrobp.2006.01.011
Peer Reviewed verified by ORBi

GULYBAN, A., Bellyei, S., Farkas, R., Strassz, A., Kovács, P., Gallainé, D. F., Dérczy, K., Hideghéty, K., & Ésik, O. (2005). Az emlőbesugárzásnál alkalmazott tangenciális mezők multiszegmentálásával javiitható a céltérfogat dózis-homogenitása. Magyar Onkologia, 45 (265), 2005.
Peer Reviewed verified by ORBi

Contact ORBi